Testing effectiveness (Phase 2)Ended earlyNCT01871480
What this trial is testing
CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung Cancer
Who this might be right for
Non-Small Cell Lung Cancer
Kunming Medical University 50